The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
The IRF family of transcription factors: Inception, impact and implications in oncogenesis
Open accessAbstract
Members of the interferon-regulatory factor (IRF) proteins family were originally identified as transcriptional regulators of the Type I interferon system. Thanks to consistent advances made in our understanding of the immunobiology of innate receptors, it is now clear that several IRFs are critical for the elicitation of innate pattern recognition receptors, and-as a consequence-for adaptive immunity. In addition, IRFs have attracted great attentions as they modulate cellular responses that are involved in tumorigenesis. The regulation of oncogenesis by IRFs has important implications for understanding the host susceptibility to several Types of cancers, their progression, as well as the potential for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Borzoi correctly predicts the upregulation of SHTN1 expression owing to the creation of a CEBP binding motif69–72 (see Supplementary Fig. 9a and Extended Data Fig. 6a,b for additional examples).”
From Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation (2025) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Papillomaviruses and cancer: from basic studies to clinical application
Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,031
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,229
Self-citationHonda, K., & Taniguchi, T. (2006) · Nature reviews. Immunology · doi:10.1038/nri1900 · Cited by 1,716
Self-citationIRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Self-citationGuichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,522
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,457
Inflammation meets cancer, with NF-κB as the matchmaker
Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,408
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,342
Self-citationThe IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259
Self-citationLi, K., Foy, E. M., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 971
Self-citationHarada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
Self-citationMolecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV
Moore, P. S., Boshoff, C., Weiss, R. A., & Chang, Y. (1996) · Science · doi:10.1126/science.274.5293.1739 · Cited by 900
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes
Kondo, S., Schutte, B. C., Richardson, R. J., Bjork, B. C., Knight, A. S., Watanabe, Y., Howard, E., de Lima, R. L. L. F., Daack‐Hirsch, S., Sander, A., et al. (2002) · Nature Genetics · doi:10.1038/ng985 · Cited by 899
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Self-citationIRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 631
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 576
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 540
Antiviral innate immunity pathways
Seth, R. B., Sun, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310019 · Cited by 492
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationSilencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N. E., Samarajiwa, S. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2830 · Cited by 487
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480
Levy, D. E., Kessler, D. S., Pine, R. I., & Darnell, J. E., Jr. (1989) · Genes & Development · doi:10.1101/gad.3.9.1362 · Cited by 468
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2
Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., & Taniguchi, T. (1993) · Science · doi:10.1126/science.8438157 · Cited by 436
Self-citationAn IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationDeletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia
Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 380
Self-citationViral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation
Schröder, M., Baran, M., & Bowie, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.143 · Cited by 374
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4
Hsu, L.-C., Park, J. M., Zhang, K., Luo, J., Maeda, S., Kaufman, R. J., Eckmann, L., Guiney, D. G., & Karin, M. (2004) · Nature · doi:10.1038/nature02405 · Cited by 357
Ingraham, C. R., Kinoshita, A., Kondo, S., Yang, B., Sajan, S. A., Trout, K. J., Malik, M., Dunnwald, M., Goudy, S. L., Lovett, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1903 · Cited by 356
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Iida, S., Rao, P. H., Butler, M. P., Corradini, P., Boccadoro, M., Klein, B., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 336
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
Park, J. S., Kim, E., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 333
Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch
Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R., Shore, P., Whitmarsh, A. J., & Dixon, M. J. (2006) · Nature Genetics · doi:10.1038/ng1894 · Cited by 325
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., & Taniguchi, T. (1996) · Nature · doi:10.1038/382816a0 · Cited by 324
Self-citationKessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Regulation of immunity and oncogenesis by the IRF transcription factor family
Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298
Self-citationPaun, A., & Pitha, P. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.014 · Cited by 277
Yu, Y., Wang, S. E., & Hayward, G. S. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.011 · Cited by 274
DiPerna, G., Stack, J., Bowie, A., Boyd, A., Kotwal, G. J., ZHANG, Z., Arvikar, S. L., Latz, E., Fitzgerald, K. A., & Marshall, W. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400567200 · Cited by 238
Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T., & Hakoshima, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5028 · Cited by 223
Self-citationRole of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression
Yanai, H., Chen, H.-M., Inuzuka, T., Kondo, S., Mak, T. W., Takaoka, A., Honda, K., & Taniguchi, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611559104 · Cited by 219
Self-citationBurýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M. J., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 212
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
Feldman, A. L., Law, M., Remstein, E. D., Macon, W. R., Erickson, L. A., Grogg, K. L., Pj, K., & Doǧan, A. (2008) · Leukemia · doi:10.1038/leu.2008.320 · Cited by 210
Barro, M., & Patton, J. T. (2007) · Journal of Virology · doi:10.1128/jvi.02498-06 · Cited by 205
Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199
IRF4: Immunity. Malignancy! Therapy?
Shaffer, A. L., Emre, N. C. T., Romesser, P. B., & Staudt, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1845 · Cited by 197
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 196
Self-citationYamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196
Self-citationTLR pathways and IFN‐regulatory factors: To each its own
Colonna, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200637009 · Cited by 193
The Interferon Regulatory Factor Family in Host Defense: Mechanism of Action
Ozato, K., Tailor, P. B., & Kubota, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700003200 · Cited by 191
Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L., & Stein, G. S. (1995) · Nature · doi:10.1038/377362a0 · Cited by 189
Self-citationTailor, P. B., Tamura, T., Kong, H. J., Kubota, T., Kubota, M., Borghi, P., Gabriele, L., & Ozato, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.009 · Cited by 179
Kondo, T., Minamino, N., Nagamura‐Inoue, T., Matsumoto, M., Taniguchi, T., & Tanaka, N. (1997) · Oncogene · doi:10.1038/sj.onc.1201286 · Cited by 177
Self-citationInterferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.
Barnes, B. J., Kellum, M. J., Pinder, K. E., Frisancho, J. A., & Pitha, P. M. (2003) · PubMed · Cited by 175
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53
Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205459 · Cited by 164
The IRF-3 Transcription Factor Mediates Sendai Virus-Induced Apoptosis
Heylbroeck, C., Balachandran, S., Servant, M. J., DeLuca, C., Barber, G. N., Lin, R., & Hiscott, J. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3781-3792.2000 · Cited by 162
Nehyba, J., Hrdličková, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 153
Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74081-2 · Cited by 152
Interferon regulatory factor family of transcription factors and regulation of oncogenesis
Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 152
Self-citationMeraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143
Joo, C. H., Shin, Y. C., Gack, M. U., Wu, L., Levy, D. E., & Jung, J. U. (2007) · Journal of Virology · doi:10.1128/jvi.00235-07 · Cited by 142
Inhibition of p300 Histone Acetyltransferase by Viral Interferon Regulatory Factor
Li, M., Damania, B., Alvarez, X., Ogryzko, V., Ozato, K., & Jung, J. U. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8254-8263.2000 · Cited by 142
Moretti, F., Marinari, B., Iacono, N. L., Botti, E., Giunta, A., Spallone, G., Garaffo, G., Vernersson-Lindahl, E., Merlo, G. R., Mills, A. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40267 · Cited by 140
Kano, A., Haruyama, T., Akaike, T., & Watanabe, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0276 · Cited by 137
Interferon regulatory factor-3 is an in vivo target of DNA-PK
Karpova, A. Y., Trost, M., Murray, J. M., Cantley, L. C., & Howley, P. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052713899 · Cited by 129
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 127
Nozawa, H., Oda, E., Nakao, K., Ishihara, M., Ueda, S., Yokochi, T., Ogasawara, K., Nakatsuru, Y., SHIMIZU, S., Ohira, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.10.1240 · Cited by 123
Self-citationHu, G., Mancl, M. E., & Barnes, B. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0583 · Cited by 121
IRF6 is a mediator of Notch pro‐differentiation and tumour suppressive function in keratinocytes
Restivo, G., Nguyen, B.-C., Dziunycz, P., Ristorcelli, E., Ryan, R. J. H., Yalcin-Ozuysal, Ö., Piazza, M., Radtke, F., Dixon, M. J., Hofbauer, G. F. L., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.325 · Cited by 118
Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hirai, H., & Taniguchi, T. (1994) · PubMed · Cited by 114
Self-citationNing, S., Campos, A. R., Darnay, B. G., Bentz, G. L., & Pagano, J. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-08 · Cited by 114
Interferon Regulatory Factor 3 Is a Cellular Partner of Rotavirus NSP1
Graff, J. W., Mitzel, D., Weisend, C. M., Flenniken, M. L., & Hardy, M. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9545-9550.2002 · Cited by 114
Bailey, C. M., Abbott, D. E., Margaryan, N. V., Khalkhali‐Ellis, Z., & Hendrix, M. J. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01866-07 · Cited by 113
Epstein‐Barr Virus: The First Human Tumor Virus and its Role in Cancer
Pagano, J. S. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.t01-1-99220.x · Cited by 111
Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y. A., Terashima, M., Saito, K., & Satodate, R. (1996) · PubMed · Cited by 105
Activation of Interferon Regulatory Factor 3 in Response to DNA-damaging Agents
Kim, T. I., Kim, T. Y., Song, Y., Min, I. M., Yim, J., & Kim, T. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30686 · Cited by 102
Burchert, A. (2003) · Blood · doi:10.1182/blood-2003-08-2970 · Cited by 102
Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κB
Jeay, S., Pianetti, S., Kagan, H. M., & Sonenshein, G. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2251-2263.2003 · Cited by 97
Yang, D., Thangaraju, M., Greeneltch, K. M., Browning, D. D., Schoenlein, P. V., Tamura, T., Ozato, K., Ganapathy, V., Abrams, S. I., & Liu, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4068 · Cited by 94
Yamamoto, H., Lamphier, M. S., Fujita, T., Taniguchi, T., & Harada, H. (1994) · PubMed · Cited by 91
Self-citationPamment, J., Ramsay, E., Kelleher, M., Dornan, D., & Ball, K. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205981 · Cited by 90
Common deleted region on the long arm of chromosome 5 in esophageal carcinoma
Ogasawara, S., Tamura, G., Maesawa, C., Suzuki, Y. A., Ishida, K., Satoh, N., Uesugi, N., Saito, K., & Satodate, R. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536888 · Cited by 89
Cell Cycle Regulation of Histone H4 Gene Transcription Requires the Oncogenic Factor IRF-2
Vaughan, P. S., van der Meijden, C. M. J., Aziz, F., Harada, H., Taniguchi, T., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.194 · Cited by 83
Self-citationTan, R. S., Taniguchi, T., & Harada, H. (1996) · PubMed · Cited by 83
Self-citationSuppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
Tanaka, N., Ishihara, M., & Taniguchi, T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90318-2 · Cited by 80
Self-citationLee, K. Y., Geng, H., Ng, K. M., Yu, J. Q., van Hasselt, A., Cao, Y., Zeng, Y.-X., Wong, A., Wang, X., Ying, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.147 · Cited by 78
Schmidt, M., Hochhaus, A., Nitsche, A., Hehlmann, R., & Neubauer, A. (2001) · Blood · doi:10.1182/blood.v97.11.3648 · Cited by 77
Interferon regulatory factor‐1 mediates interferon‐γ‐induced apoptosis in ovarian carcinoma cells
Kim, E., Lee, J.-M., Namkoong, S., Um, S., & Park, J. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10142 · Cited by 75
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5
Wies, E., Hahn, A. S., Schmidt, K. M., Viebahn, C., Rohland, N., Lux, A., Schellhorn, T., Holzer, A., Jung, J. U., & Neipel, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809252200 · Cited by 73
IRF8 Regulates Acid Ceramidase Expression to Mediate Apoptosis and Suppresses Myelogeneous Leukemia
Hu, X., Yang, D., Zimmerman, M. A., Liu, F., Yang, J., Kannan, S., Burchert, A., Szulc, Z. M., Bielawska, A. E., Ozato, K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2493 · Cited by 72
A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis
Couzinet, A., Tamura, K., Chen, H., Nishimura, K., Wang, Z., Morishita, Y., Takeda, K., Yagita∥, H., Yanai, H., Taniguchi, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712295105 · Cited by 71
Self-citationInterferon Regulatory Factor Expression in Human Breast Cancer
Doherty, G. M., Boucher, L. D., Sorenson, K., & Lowney, J. K. (2001) · Annals of Surgery · doi:10.1097/00000658-200105000-00005 · Cited by 71
Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target
Kirshner, J. R., Karpova, A. Y., Kops, M., & Howley, P. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9320-9324.2005 · Cited by 70
WEAVER, B. K., ANDO, O., Kumar, K. P., & Reich, N. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0222com · Cited by 68
Li, Q., & Tainsky, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028683 · Cited by 68
Zhang, L., Zhang, J., Lambert, Q. T., Der, C. J., Valle, L. D., Judith Miklossy, A., Khalili, K., Zhou, Y., & Pagano, J. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12987-12995.2004 · Cited by 66
Bi, X., Hameed, M., Mirani, N. M., Pimenta, E. M., Anari, J. B., & Barnes, B. J. (2011) · Breast Cancer Research · doi:10.1186/bcr3053 · Cited by 66
Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis
Park, J., Kim, K., Lee, E., Seo, Y.-J., Lim, S., Park, K., Rho, S. B., Lee, S., & Lee, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609852104 · Cited by 63
A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 63
ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells
Tamura, T., Kong, H. J., Tunyaplin, C., Tsujimura, H., Calame, K. L., & Ozato, K. (2003) · Blood · doi:10.1182/blood-2003-01-0291 · Cited by 61
Tomita, Y., Bilim, V. N., Hara, N., Kasahara, T., & Takahashi, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.10956 · Cited by 59
Interferon Regulatory Factor-2 Regulates Cell Growth through Its Acetylation
Masumi, A., Yamakawa, Y., Fukazawa, H., Ozato, K., & Komuro, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213037200 · Cited by 55
IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia
Pathak, S., Ma, S., Trinh, L., Eudy, J. D., Wagner, K., Joshi, S. S., & Lu, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022628 · Cited by 55
Huang, W., Zhu, C., Wang, H., Horvath, E., & Eklund, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706710200 · Cited by 54
Kaposi Sarcoma Herpesvirus-Encoded Interferon Regulator Factors
Offermann, M. K. (2006) · Springer eBooks · doi:10.1007/978-3-540-34344-8_7 · Cited by 51
Schmidt, M., Hochhaus, A., König-Merediz, S. A., Brendel, C. A., Proba, J., Hoppe, G. J., Wittig, B., Ehninger, G., Hehlmann, R., & Neubauer, A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3331 · Cited by 51
Nguyen, H. T. T., Mustafa, A., Hiscott, J. B., & Lin, R. (1995) · PubMed · Cited by 51
Deng, M., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.11.3491 · Cited by 50
Song, Y., Izumi, K. M., Shinners, N. P., Gewurz, B. E., & Kieff, E. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809933105 · Cited by 49
In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay, D., Mercier, F., Stagg, J., Martineau, D., Bramson, J. L., Servant, M. J., Lin, R., Galipeau, J., & Hiscott, J. B. (2002) · PubMed · Cited by 49
Liu, K., & Abrams, S. I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6329 · Cited by 46
IRF6 in development and disease: A mediator of quiescence and differentiation
Bailey, C. M., & Hendrix, M. J. C. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6221 · Cited by 46
Dror, N., Rave-Harel, N., Burchert, A., Azriel, A., Tamura, T., Tailor, P. B., Neubauer, A., Ozato, K., & Levi, B.-Z. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607825200 · Cited by 44
Oncogenic Potential of a Dominant Negative Mutant of Interferon Regulatory Factor 3
Kim, T. Y., Lee, K.-H., Chang, S., Chung, C., Lee, H.-W., Kim, T. K., & Kim, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205792200 · Cited by 42
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer
Cavalli, L. R., Riggins, R. B., Wang, A., Clarke, R. C., & Haddad, B. R. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0509-8 · Cited by 41
Ortmann, C. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1001 · Cited by 40
The interferon-inducible murine p48 (ISGF3γ) gene is regulated by protooncogene c- myc
Weihua, X., Lindner, D. J., & Kalvakolanu, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7227 · Cited by 39
Tzoanopoulos, D., Speletas, M. G., Arvanitidis, K. I., Veiopoulou, C., Kyriaki, S., Thyphronitis, G., Sideras, P., Kartalis, G., & Ritis, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03829.x · Cited by 38
Pettersson, S., Kelleher, M., Pion, E., Wallace, M., & Ball, K. L. (2008) · Biochemical Journal · doi:10.1042/bj20082087 · Cited by 37
Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma
Heintel, D., Zojer, N., Schreder, M., Strasser‐Weippl, K., Kainz, B., Vesely, M., Gisslinger, H., Drach, J. W., Gaiger, A., Jaeger, U., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404895 · Cited by 36
Repression of IRF-4 target genes in human T cell leukemia virus-1 infection
Mamane, Y., Grandvaux, N., Hernandez, E., Sharma, S., Innocente, S. A., Lee, J. M., Azimi, N., Lin, R., & Hiscott, J. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205843 · Cited by 35
Yilmaz, A., Bieler, G., Spertini, O., Lejeune, F. J., & Rüegg, C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4 · Cited by 34
Self-citationN-Ras –Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1
Passioura, T., Dolnikov, A., Shen, S., & Symonds, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.797.65.3 · Cited by 33
IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells
Cui, L., Deng, Y., Rong, Y., Lou, W., Mao, Z., Feng, Y., Xie, D., & Jin, D. (2011) · Tumor Biology · doi:10.1007/s13277-011-0273-3 · Cited by 32
Narayan, V., Halada, P., Hernychová, L., Chong, Y., Žáková, J., Hupp, T. R., Vojtěšek, B., & Ball, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204602 · Cited by 28
Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5
Yang, L., Zhao, T., Shi, X., Nakhaei, P., Wang, Y., Sun, Q., Hiscott, J. B., & Lin, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005500 · Cited by 27
ICSAT Overexpression Is Not Sufficient to Cause Adult T-Cell Leukemia or Multiple Myeloma
Saito, T., Yamagata, T., Takahashi, T., Honda, H., & Hirai, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0911 · Cited by 17
GAAP‐1: a transcriptional activator of p53 and IRF‐1 possesses pro‐apoptotic activity
Lallemand, C., Palmieri, M., Blanchard, B., Méritet, J., & Tovey, M. G. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf032 · Cited by 17
Passioura, T., Shen, S., Symonds, G. P., & Dolnikov, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208877 · Cited by 15
Aberrant expression of interferon regulatory factor 3 in human lung cancer
Tokunaga, T., Naruke, Y., Shigematsu, S., Kohno, T., Yasui, K., Ma, Y., Chua, K. J., Katayama, I., Nakamura, T., Hishikawa, Y., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.085 · Cited by 15
Venâncio, T. M., Demarco, R. C., Almeida, G. T., Oliveira, K. C., Setúbal, J. C., & Verjovski‐Almeida, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-407 · Cited by 13
Repression of DNA Repair Mechanisms in IRF-4-Expressing and HTLV-I-Infected T Lymphocytes
Mamane, Y., Loignon, M., Palmer, J., Hernandez, E., Césaire, R., Alaoui‐Jamali, M. A., & Hiscott, J. B. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.43 · Cited by 10
Oshita, F., Sekiyama, A., Ito, H., Kameda, Y., & Miyagi, Y. (2006) · Oncology Reports · doi:10.3892/or.16.4.817 · Cited by 10
The second ETV6 allele is not necessarily deleted in acute leukemias with aETV6/ABL fusion
Hannemann, J., Healy, L. E., Ridge, S. A., & Wiedemann, L. M. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199803)21:3 · Cited by 8
Flagged first, then by citations
Research works printed but not linked: 9
- Tan RS, 1996, Cancer Res, 56, 2417
- Harada H, 1994, Oncogene, 9, 3313
- Tamura G, 1996, Cancer Res, 56, 612
- Nguyen H, 1995, Oncogene, 11, 537
- Yamamoto H, 1994, Oncogene, 9, 1423
- Oshita F, 2006, Oncol Rep, 16, 817
- Duguay D, 2002, Cancer Res, 62, 5148
- Barnes BJ, 2003, Cancer Res, 63, 6424
- Burysek L, 1999, J Hum Virol, 2, 19
Cited by
Sorted by citations
Negishi, H., Taniguchi, T., & Yanai, H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 447
Self-citationRegulating IRFs in IFN Driven Disease
Jefferies, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00325 · Cited by 364
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311
Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation
Linder, J., Srivastava, D., Yuan, H., Agarwal, V., & Kelley, D. R. (2025) · Nature Genetics · doi:10.1038/s41588-024-02053-6 · Cited by 265
The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune ResponsesPreprint
Ikushima, H., Negishi, H., & Taniguchi, T. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020321 · Cited by 273
Self-citation
Metadata
- Authors
- Yanai, H., Negishi, H., & Taniguchi, T.
- Affiliations
- Japan Science and Technology Agency (JP)
- Corresponding author
- Taniguchi, Tadatsugu
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2012-11
- Volume
- 1
- Issue
- 8
- Pages
- 1376-1386
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- PMC
- PMC3518510
- OpenAlex
- W2031904443
- Cited by
- 261
- References
- 140
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 24 · 2023: 22 · 2022: 32 · 2021: 29 · 2020: 25 · 2019: 26 · 2018: 21 · 2017: 14 · 2016: 8 · 2015: 9 · 2014: 12 · 2013: 6
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- OncoImmunology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- interferon regulatory factors, transcription factors, type I interferon, innate immunity, pattern recognition receptors, adaptive immunity, carcinogenesis, cancer susceptibility, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review